Jane Street »

Chemomab Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $26k 16k 1.65
2025-09-30 $57k 22k 2.63

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Chemomab Therapeutics

ADAR1 Capital Management
Ikarian Capital
Kestra Private Wealth Services
XTX Topco
Rhumbline Advisers
Jane Street
Virtu Financial
Bnp Paribas Arbitrage, Snc
GAMMA Investing
UBS Group
SBI Securities
Northwestern Mutual Wealth Management Company

View all funds holding Chemomab Therapeutics